TUBGCP5

TUBGCP5 (GCP5) is a structural subunit of the human γ-tubulin ring complex (γ-TuRC), the cellular machine that nucleates microtubules at the centrosome, and it is present as a single copy within the purified, nucleation-competent complex (PMID:11694571). Structural and biochemical work places GCP5 alongside GCP4 and GCP6 in distinct Y-shaped assemblies that mimic the core GCP2/GCP3 subcomplexes and sit distal to the asymmetric 'seam' of the cone-shaped γ-TuRC, helping arrange γ-tubulins into the helical geometry required for nucleation (PMID:31862189). The N-terminal domain of GCP5 defines its identity and mediates lateral association with neighboring GCPs, while exchangeable C-terminal grip domains engage γ-tubulin, with γ-tubulin binding itself dispensable for integration into the helical complex (PMID:27660388, PMID:21725292). GCP5 assembles with two copies of GCP4 and one copy of GCP6 into a salt-resistant sub-complex that forms independently of γ-TuSCs and reconstitutes functional γ-TuRCs when combined with γ-TuSC-containing extracts (PMID:32317396), and GCP5/6-specific extensions, together with NEDD1, anchor the assembled complex to the pericentriolar material (PMID:40074789). Functionally, GCP5 is required for γ-TuRC integrity and for recruitment of γ-tubulin to mitotic spindle poles; it binds GSK-3β directly and acts downstream of GSK-3β to control γ-TuRC localization and proper spindle organization (PMID:18316369). Loss of TUBGCP5 in vivo causes mitotic arrest, disorganized spindles, and p53-dependent loss of hematopoietic stem and progenitor cells (PMID:42092188).

1. 2001 High

   Established that GCP5 is a genuine, single-copy component of the microtubule-nucleating γ-TuRC rather than a loosely associated factor, defining its place in the complex.

   Evidence Mass spectrometry, stoichiometry, immunolocalization and in vitro nucleation of purified human γ-TuRC

   PMID:11694571

   Open questions at the time

   • Did not resolve where GCP5 sits within the complex architecture
   • No domain-level mechanism of how GCP5 contributes to nucleation
2. 2006 Medium

   Ortholog genetics showed GCP5 is peripherally associated and quantitatively, not qualitatively, required for nucleation, distinguishing it from core γ-TuC subunits.

   Evidence Genetic deletion of mod21 (GCP5 ortholog), co-IP and sucrose gradients in fission yeast

   PMID:17021256

   Open questions at the time

   • Cross-kingdom ortholog inference may not fully translate to human GCP5
   • Did not define molecular interactions at residue or domain level
3. 2008 High

   Connected GCP5 to a regulatory signaling input by showing it binds GSK-3β and is required for γ-TuRC stability and γ-tubulin recruitment to spindle poles, placing it downstream of GSK-3β.

   Evidence In vitro binding, endogenous co-IP, sucrose gradients, siRNA depletion and epistasis rescue in human cells

   PMID:18316369

   Open questions at the time

   • Whether GSK-3β phosphorylates GCP5 directly not established
   • Mechanism by which GCP5 loss destabilizes the complex not resolved
4. 2011 High

   Solved the GCP4 crystal structure as a structural prototype for all GCPs including GCP5, defining the conserved C-terminal γ-tubulin-binding architecture.

   Evidence X-ray crystallography, cryo-EM fitting and in vitro binding

   PMID:21725292

   Open questions at the time

   • Direct GCP5 structure inferred rather than solved
   • GCP5-specific extensions and regulatory regions not modeled
5. 2016 High

   Defined the division of labor between GCP domains, showing GCP5's N-terminal domain confers identity and mediates lateral GCP-GCP association while C-terminal domains are exchangeable.

   Evidence Chimeric domain-swapping and FLIM-FRET in cells

   PMID:27053664 PMID:27660388

   Open questions at the time

   • Functional consequence of GCP5's distinct role versus GCP6 at spindle poles only shown in yeast
   • Lateral interface residues not mapped
6. 2020 High

   Demonstrated that GCP5 nucleates the formation of a salt-resistant GCP4/5/6 sub-complex that assembles independently and seeds functional γ-TuRC reconstitution.

   Evidence Biochemical purification, salt-resistance and in vitro γ-TuRC reconstitution with nucleation assay

   PMID:32317396

   Open questions at the time

   • Order and kinetics of sub-complex assembly in cells unknown
   • Stoichiometric assembly determinants not defined
7. 2019 High

   Resolved the native human γ-TuRC at near-atomic resolution, placing GCP5 in a Y-shaped assembly distal to the seam that helps impose nucleation-competent helical geometry.

   Evidence Cryo-EM and pseudo-atomic modeling of native complex

   PMID:31862189

   Open questions at the time

   • How the asymmetric GCP4/5/6 region tunes nucleation efficiency not mechanistically resolved
8. 2025 High

   Identified GCP5/6-specific extensions as a structural docking point for NEDD1, explaining how the γ-TuRC is anchored to the pericentriolar material.

   Evidence Cryo-electron tomography of γ-TuRCs in cells and purified centrosomes

   PMID:40074789

   Open questions at the time

   • Whether GCP5 versus GCP6 extensions contribute differentially to NEDD1 binding unresolved
9. 2026 Medium

   Linked TUBGCP5 loss to a physiological outcome, showing it is required for hematopoietic stem cell self-renewal via proper spindle formation.

   Evidence Genetic disruption in zebrafish with time-lapse imaging and lineage tracing

   PMID:42092188

   Open questions at the time

   • TUBGCP5 tested in parallel with other subunits, so subunit-specific contribution not isolated
   • Mechanism linking spindle defect to symmetric differentiation choice not defined

• How GCP5-specific regulation (e.g. GSK-3β signaling, mRNA processing) and tissue-specific roles integrate with its conserved structural function in the γ-TuRC remains open.
• No direct demonstration that GCP5 is a GSK-3β phosphorylation substrate
• Functional consequence of FASTKD2/EFTUD2 binding to TUBGCP5 mRNA not established
• Mechanism of TUBGCP5 role in cardiomyocyte differentiation uncharacterized